LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk

Clin Pharmacol Ther. 2018 Aug;104(2):235-238. doi: 10.1002/cpt.1125. Epub 2018 Jul 13.

Authors

Richard Ofori-Asenso^{1

2}, Sophia Zoungas³, Andrew Tonkin⁴, Danny Liew¹

Affiliations

¹ Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
² Epidemiological Modelling Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
³ Division of Metabolism, Genomics and Ageing, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
⁴ Cardiovascular Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

PMID: 30004113
DOI: 10.1002/cpt.1125

No abstract available

MeSH terms

Acute Coronary Syndrome / blood
Acute Coronary Syndrome / diagnosis*
Acute Coronary Syndrome / epidemiology
Acute Coronary Syndrome / therapy
Biomarkers / blood
Cholesterol, LDL / blood*
Clinical Decision-Making
Coronary Artery Disease / blood
Coronary Artery Disease / diagnosis*
Coronary Artery Disease / epidemiology
Coronary Artery Disease / therapy
Humans
Predictive Value of Tests
Prognosis
Reproducibility of Results
Risk Assessment
Risk Factors

Substances

Biomarkers
Cholesterol, LDL